SWASTITradeDesk
Public catalog
SE
3D-MPLA supplied by Swasti Exports

Vaccine Adjuvants

3D-MPLA

Extracted from the cell wall components of Salmonella minnesota R595, followed by precise dephosphorylation and alkaline hydrolysis. Applications: As the world’s most widely utilized TLR4-based adjuvant in clinical practice, our technology has powered a diverse portfolio of licensed vaccines.1 Approved Oncology Vaccine.2 Approved Allergy Vaccines.4 Approved Human Infectious Disease Vaccines Quality level: Research grade / GMP grade

Product codeGC07003
GradeResearch grade / GMP grade
Source categoryMonophosphoryl Lipid A
Active ingredientsExtracted from the cell wall components of Salmonella minnesota R595, followed by precise dephosphorylation and alkaline hydrolysis.
ApplicationsAs the world’s most widely utilized TLR4-based adjuvant in clinical practice, our technology has powered a diverse portfolio of licensed vaccines.1 Approved Oncology Vaccine.2 Approved Allergy Vaccines.4 Approved Human Infectious Disease Vaccines